---
layout: post
title: "Grant of Interim Extension of the Term of U.S. Patent No. 6,406,699; ECI® (ELIAS Cancer Immunotherapy)"
date: 2026-02-05 19:00:55 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-21118
original_published: 2022-09-29 00:00:00 +0000
significance: 8.00
---

# Grant of Interim Extension of the Term of U.S. Patent No. 6,406,699; ECI® (ELIAS Cancer Immunotherapy)

**Published:** February 05, 2026 19:00 UTC
**Source:** Federal Register
**Original Published:** September 29, 2022 00:00 UTC
**Document Number:** 2022-21118

## Summary

The United States Patent and Trademark Office has issued an order granting a one-year interim extension of the term of U.S. Patent No. 6,406,699 ('699 patent).

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/09/29/2022-21118/grant-of-interim-extension-of-the-term-of-us-patent-no-6406699-eci-elias-cancer-immunotherapy)
- API: https://www.federalregister.gov/api/v1/documents/2022-21118

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
